This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Thomas Adam: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Adam is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds.
Latest Patents
One of his key patents is titled "Process for preparing pradofloxacin." This invention relates to an improved method for synthesizing pradofloxacin, where the substituent in the 7 position is introduced through nucleophilic substitution in a solvent mixture of N-methylpyrrolidone and ethanol. This innovative approach enhances the efficiency and effectiveness of the synthesis process.
Career Highlights
Throughout his career, Thomas Adam has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Intellectual Property GmbH and Bayer Animal Health GmbH, where he has contributed to various research and development projects.
Collaborations
Thomas has collaborated with esteemed colleagues, including Klaus Weidemann and Ralf Wischnat. These partnerships have further enriched his work and have led to advancements in pharmaceutical innovations.
Conclusion
Thomas Adam's contributions to the field of pharmaceutical chemistry, particularly through his patent for pradofloxacin, highlight his role as an influential inventor. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile